Maxwell DeNies
Analyst·RA Capital Management
Maxwell DeNies is an Analyst on RA Capital's Investment Team, where he conducts diligence on biotechnology companies and advises portfolio companies on program and pipeline strategy. A separate Incyclix Bio board-observer bio describes him as a Senior Associate in RA Capital's TechAtlas division working with the Investment Team to build conviction in potential investments and advise portfolio companies. He joined RA Capital after doctoral research in cellular and molecular biology at the University of Michigan.
See the rest of Maxwell DeNies's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.